Thursday, February 22, 2024
Home Tags Eftilagimod Alpha

Tag: Eftilagimod Alpha

Immutep gets green light for large-scale cancer product manufacturing for clinical trials

Immutep Limited, a clinical-stage biotechnology company specialising in LAG-3 immunotherapies for cancer and autoimmune diseases, has received regulatory authorisation for the commercial manufacturing of Eftilagimod Alpha (efti) at a scale of 2,000 litres for clinical trial use. 
Advertisement

Safe Direction

PP Shim

Wilsons Solar & Electrical

Featured Article

The Intelligent Manufacturing Forum: Automation pathways for Australian manufacturers

The Australian manufacturing sector is navigating increasingly rapid changes in industry dynamics as more technological advancements are adopted worldwide.